Recap: Arcadia Biosciences Q4 Earnings

Arcadia Biosciences, Inc. +0.33%

Arcadia Biosciences, Inc.




Arcadia Biosciences (NASDAQ:RKDA) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.


Arcadia Biosciences beat estimated earnings by 19.0%, reporting an EPS of $-2.1 versus an estimate of $-2.58.

Revenue was up $170 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.3 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Arcadia Biosciences's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -3.19 -4.80 -6.85 -6.80
EPS Actual -1.89 -2.64 -10.86 -6.31
Revenue Estimate 1.55M 1.82M 1.40M 2.00M
Revenue Actual 1.60M 1.39M 1.51M 1.00M

To track all earnings releases for Arcadia Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via